Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

15.66 USD +0.47 (+3.09%)
Official Closing Price Updated: 7:57 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 653,500
Open 15.31
Bid (Size) 15.22 (2)
Ask (Size) 15.68 (1)
Prev. Close 15.19
Today's Range 15.05 - 15.70
52wk Range 4.650 - 21.93
Shares Outstanding 84,478,054
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today... 
From Business Wire News Releases
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced Time Is Nephrons, the first-ever lupus nephritis (LN) disease-state awareness campaign for healthcare... 
From Business Wire News Releases

Performance

YTD
-27.03%
-27.03%
1 Month
+11.54%
+11.54%
3 Month
+13.64%
+13.64%
6 Month
-3.87%
-3.87%
1 Year
+221.56%
+221.56%

More News

Read More
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome
From Business Wire News Releases
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences
From Business Wire News Releases
Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights
From Business Wire News Releases
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
From Business Wire News Releases
Short Interest Ratio Indicates Bullish Canadian Stocks: $PAAS $REAL $AUP
Tags The Market Signal
From The Market Signal
Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020
From Business Wire News Releases
Aurinia Closes US$200 Million Public Offering of Common Shares
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.